Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1

Christian Ghiglione, Laufey Amundadottir, Margret Andresdottir, David Bilder, John A. Diamonti, Stéphane Noselli, Norbert Perrimon, Kermit L Carraway

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The transmembrane protein Kekkon 1 (Kek1) has previously been shown to act in a negative feedback loop to downregulate the Drosophila Epidermal Growth Factor Receptor (DER) during oogenesis. We show that this protein plays a similar role in other DER-mediated developmental processes. Structure-function analysis reveals that the extracellular Leucine-Rich Repeat (LRR) domains of Kek1 are critical for its function through direct association with DER, whereas its cytoplasmic domain is required for apical subcellular localization. In addition, the use of chimeric proteins between Kek1 extracellular and transmembrane domains fused to DER intracellular domain indicates that Kek1 forms an heterodimer with DER in vivo. To characterize more precisely the mechanism underlying the Kek1/DER interaction, we used mammalian ErbB/EGFR cell-based assays. We show that Kek1 is capable of physically interacting with each of the known members of the mammalian ErbB receptor family and that the Kek1/EGFR interaction inhibits growth factor binding, receptor autophosphorylation and Erk1/2 activation in response to EGF. Finally, in vivo experiments show that Kek1 expression potently suppresses the growth of mouse mammary tumor cells derived from aberrant ErbB receptors activation, but does not interfere with the growth of tumor cells derived from activated Ras. Our results underscore the possibility that Kek1 may be used experimentally to inhibit ErbB receptors and point to the possibility that, as yet uncharacterized, mammalian transmembrane LRR proteins might act as modulators of growth factor signalling.

Original languageEnglish (US)
Pages (from-to)4483-4493
Number of pages11
JournalDevelopment
Volume130
Issue number18
DOIs
StatePublished - Sep 2003

Fingerprint

Drosophila
Tumor-Infiltrating Lymphocytes
Oogenesis
Proteins
Growth Factor Receptors
Growth
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Leucine
Intercellular Signaling Peptides and Proteins
Down-Regulation
Breast Neoplasms
ErbB Receptors
leucine-rich repeat proteins

Keywords

  • EGFR
  • kek1
  • LRR domains
  • Mammary tumor
  • Negative feedback loop

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology

Cite this

Ghiglione, C., Amundadottir, L., Andresdottir, M., Bilder, D., Diamonti, J. A., Noselli, S., ... Carraway, K. L. (2003). Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1. Development, 130(18), 4483-4493. https://doi.org/10.1242/dev.00617

Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1. / Ghiglione, Christian; Amundadottir, Laufey; Andresdottir, Margret; Bilder, David; Diamonti, John A.; Noselli, Stéphane; Perrimon, Norbert; Carraway, Kermit L.

In: Development, Vol. 130, No. 18, 09.2003, p. 4483-4493.

Research output: Contribution to journalArticle

Ghiglione, C, Amundadottir, L, Andresdottir, M, Bilder, D, Diamonti, JA, Noselli, S, Perrimon, N & Carraway, KL 2003, 'Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1', Development, vol. 130, no. 18, pp. 4483-4493. https://doi.org/10.1242/dev.00617
Ghiglione C, Amundadottir L, Andresdottir M, Bilder D, Diamonti JA, Noselli S et al. Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1. Development. 2003 Sep;130(18):4483-4493. https://doi.org/10.1242/dev.00617
Ghiglione, Christian ; Amundadottir, Laufey ; Andresdottir, Margret ; Bilder, David ; Diamonti, John A. ; Noselli, Stéphane ; Perrimon, Norbert ; Carraway, Kermit L. / Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1. In: Development. 2003 ; Vol. 130, No. 18. pp. 4483-4493.
@article{5b082df153be471ba1bc6b1e3ad236d0,
title = "Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1",
abstract = "The transmembrane protein Kekkon 1 (Kek1) has previously been shown to act in a negative feedback loop to downregulate the Drosophila Epidermal Growth Factor Receptor (DER) during oogenesis. We show that this protein plays a similar role in other DER-mediated developmental processes. Structure-function analysis reveals that the extracellular Leucine-Rich Repeat (LRR) domains of Kek1 are critical for its function through direct association with DER, whereas its cytoplasmic domain is required for apical subcellular localization. In addition, the use of chimeric proteins between Kek1 extracellular and transmembrane domains fused to DER intracellular domain indicates that Kek1 forms an heterodimer with DER in vivo. To characterize more precisely the mechanism underlying the Kek1/DER interaction, we used mammalian ErbB/EGFR cell-based assays. We show that Kek1 is capable of physically interacting with each of the known members of the mammalian ErbB receptor family and that the Kek1/EGFR interaction inhibits growth factor binding, receptor autophosphorylation and Erk1/2 activation in response to EGF. Finally, in vivo experiments show that Kek1 expression potently suppresses the growth of mouse mammary tumor cells derived from aberrant ErbB receptors activation, but does not interfere with the growth of tumor cells derived from activated Ras. Our results underscore the possibility that Kek1 may be used experimentally to inhibit ErbB receptors and point to the possibility that, as yet uncharacterized, mammalian transmembrane LRR proteins might act as modulators of growth factor signalling.",
keywords = "EGFR, kek1, LRR domains, Mammary tumor, Negative feedback loop",
author = "Christian Ghiglione and Laufey Amundadottir and Margret Andresdottir and David Bilder and Diamonti, {John A.} and St{\'e}phane Noselli and Norbert Perrimon and Carraway, {Kermit L}",
year = "2003",
month = "9",
doi = "10.1242/dev.00617",
language = "English (US)",
volume = "130",
pages = "4483--4493",
journal = "Development (Cambridge)",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "18",

}

TY - JOUR

T1 - Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1

AU - Ghiglione, Christian

AU - Amundadottir, Laufey

AU - Andresdottir, Margret

AU - Bilder, David

AU - Diamonti, John A.

AU - Noselli, Stéphane

AU - Perrimon, Norbert

AU - Carraway, Kermit L

PY - 2003/9

Y1 - 2003/9

N2 - The transmembrane protein Kekkon 1 (Kek1) has previously been shown to act in a negative feedback loop to downregulate the Drosophila Epidermal Growth Factor Receptor (DER) during oogenesis. We show that this protein plays a similar role in other DER-mediated developmental processes. Structure-function analysis reveals that the extracellular Leucine-Rich Repeat (LRR) domains of Kek1 are critical for its function through direct association with DER, whereas its cytoplasmic domain is required for apical subcellular localization. In addition, the use of chimeric proteins between Kek1 extracellular and transmembrane domains fused to DER intracellular domain indicates that Kek1 forms an heterodimer with DER in vivo. To characterize more precisely the mechanism underlying the Kek1/DER interaction, we used mammalian ErbB/EGFR cell-based assays. We show that Kek1 is capable of physically interacting with each of the known members of the mammalian ErbB receptor family and that the Kek1/EGFR interaction inhibits growth factor binding, receptor autophosphorylation and Erk1/2 activation in response to EGF. Finally, in vivo experiments show that Kek1 expression potently suppresses the growth of mouse mammary tumor cells derived from aberrant ErbB receptors activation, but does not interfere with the growth of tumor cells derived from activated Ras. Our results underscore the possibility that Kek1 may be used experimentally to inhibit ErbB receptors and point to the possibility that, as yet uncharacterized, mammalian transmembrane LRR proteins might act as modulators of growth factor signalling.

AB - The transmembrane protein Kekkon 1 (Kek1) has previously been shown to act in a negative feedback loop to downregulate the Drosophila Epidermal Growth Factor Receptor (DER) during oogenesis. We show that this protein plays a similar role in other DER-mediated developmental processes. Structure-function analysis reveals that the extracellular Leucine-Rich Repeat (LRR) domains of Kek1 are critical for its function through direct association with DER, whereas its cytoplasmic domain is required for apical subcellular localization. In addition, the use of chimeric proteins between Kek1 extracellular and transmembrane domains fused to DER intracellular domain indicates that Kek1 forms an heterodimer with DER in vivo. To characterize more precisely the mechanism underlying the Kek1/DER interaction, we used mammalian ErbB/EGFR cell-based assays. We show that Kek1 is capable of physically interacting with each of the known members of the mammalian ErbB receptor family and that the Kek1/EGFR interaction inhibits growth factor binding, receptor autophosphorylation and Erk1/2 activation in response to EGF. Finally, in vivo experiments show that Kek1 expression potently suppresses the growth of mouse mammary tumor cells derived from aberrant ErbB receptors activation, but does not interfere with the growth of tumor cells derived from activated Ras. Our results underscore the possibility that Kek1 may be used experimentally to inhibit ErbB receptors and point to the possibility that, as yet uncharacterized, mammalian transmembrane LRR proteins might act as modulators of growth factor signalling.

KW - EGFR

KW - kek1

KW - LRR domains

KW - Mammary tumor

KW - Negative feedback loop

UR - http://www.scopus.com/inward/record.url?scp=0141836766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141836766&partnerID=8YFLogxK

U2 - 10.1242/dev.00617

DO - 10.1242/dev.00617

M3 - Article

C2 - 12900463

AN - SCOPUS:0141836766

VL - 130

SP - 4483

EP - 4493

JO - Development (Cambridge)

JF - Development (Cambridge)

SN - 0950-1991

IS - 18

ER -